Structural requirements for the substrates of the H+/peptide cotransporter PEPT2 determined by three-dimensional quantitative structure - Activity relationship analysis

Journal of Medicinal Chemistry

Volumn 49, Issue 14, 2006, Pages 4286-4296

  Biegel, Annegret ^a   Gebauer, Sabine ^a   Brandsch, Matthias ^a   Neubert, Klaus ^a   Thondorf, Iris ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; CEFACLOR; CEFADROXIL; CEFALEXIN; CEFALOTIN; CEFAMANDOLE; CEFAPIRIN; CEFAZOLIN; CEFEPIME; CEFIXIME; CEFODIZIME; CEFOTAXIME; CEFOXITIN; CEFPIROME; CEFPODOXIME; CEFRADINE; CEFTIBUTEN; CEFTRIAXONE; CEFUROXIME; CLOXACILLIN; COTRANSPORTER; CYCLACILLIN; DICLOXACILLIN; LATAMOXEF; METAMPICILLIN; OXACILLIN; PHENETICILLIN; PROTON PEPTIDE COTRANSPORTER 2; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; COMPARATIVE MOLECULAR SIMILARITY INDICES ANALYSIS; DRUG STRUCTURE; NONHUMAN; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RAT;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CEPHALOSPORINS; DIPEPTIDES; MODELS, MOLECULAR; MOLECULAR CONFORMATION; OLIGOPEPTIDES; PENICILLINS; PROTEIN BINDING; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SYMPORTERS;

EID: 33745868715     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0601811     Document Type: Article

References (59)

1. Ramamoorthy, S.; Liu, W.; Ma, Y. Y.; Yang-Feng, T. L.; Ganapathy, V.; Leibach, F. H. Proton/peptide cotransporter (PEPT 2) from human kidney: functional characterization and chromosomal localization. Biochim. Biophys. Acta 1995, 1240, 1-4.
2. Shen, H.; Smith, D. E.: Yang, T.; Huang, Y. G.; Schnermann, J. B.; Brosius, F. C. R. Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney. Am. J. Physiol. 1999, 276, F658-F665.
3. Groneberg, D. A.; Döring, F.; Nickolaus, M.; Daniel, H.; Fischer, A. Renal assimilation of short chain peptides: visualization of tubular peptide uptake. Pharm. Res. 2002, 19, 1209-1214.
4. Groneberg, D. A.; Nickolaus, M.; Springer, J.; Döring, F.; Daniel, H.; Fischer, A. Localization of the peptide transporter PEPT2 in the lung: implications for pulmonary oligopeptide uptake. Am. J. Pathol. 2001, 158, 707-714.
5. Berger, U. V.; Hediger, M. A. Distribution of peptide transporter PEPT2 mRNA in the rat nervous system. Anat. Embryol. 1999, 199, 439-449.
6. ε-AMCA in astrocytes. GLIA 1999, 25, 10-20.
7. Groneberg, D. A.; Döring, F.; Nickolaus, M.; Daniel, H.; Fischer, A. Expression of PEPT2 peptide transporter mRNA and protein in glial cells of rat dorsal root ganglia. Neurosci Lett. 2001, 304, 181-184.
8. Bühl, A.; Hoppe, S.; Frey, I.; Daniel, H.; Schemann, M. Functional expression of the peptide transporter PEPT2 in the mammalian enteric nervous system. J. Comput. Neurol. 2005, 490, 1-11.
9. Groneberg, D. A.; Döring, F.; Theis, S.; Nickolaus, M.; Fischer, A.; Daniel, H. Peptide transport in the mammary gland: expression and distribution of PEPT2 mRNA and protein. Am. J. Physiol.: Endocrinol. Metah. 2002, 282, E1172-E1179.
10. Ocheltree, S. M.; Shen, H.; Hu, Y.; Keep, R. F.; Smith, J. M. Role and relevance of PEPT2 in the kidney and choroid plexus: In vivo studies with glycylsarcosine in wild-type and PEPT2 knockout mice. J. Pharmacol. Exp. Ther. 2005, 315, 240-247.
11. Ocheltree, S. M.; Keep, R. F.; Shen, H.; Yang, D.; Hughes, B. A.; Smith. D. E. Preliminary investigation into the expression of proton-coupled oligopeptide transporters in neural retina and retinal pigment epithelium (RPE): lack of functional activity in RPE plasma membranes. Pharm. Res. 2003, 9, 1364-1372.
12. +/peptide transporter PEPT2. Brain Res. 2004, 997, 52-61.
13. Lu, H.; Klaassen, C. Tissue distribution and thyroid hormone regulation of Pept1 and Pept2 mRNA in rodents. Peptides 2005, 29.
14. Ganapathy, M. E.; Brandsch, M.; Prasad, P. D.; Ganapathy, V.; Leibach, F. H. Differential recognition of β-lactam antibiotics by intestinal and renal peptide transporters, PEPT 1 and PEPT 2. J. Biol. Chem. 1995, 270, 25672-25677.
15. Ganapathy, M. E.; Prasad, P. D.; Mackenzie, B.; Ganapathy, V.; Leibach, F. H. Interaction of anionic cephalosporines with the intestinal and renal peptide transporters PEPT1 and PEPT2. Biochim. Biophys. Acta 1997, 1324, 296-308.
16. Sugawara, M.; Huang, W.; Fei, Y. J.; Leibach, F. H.; Ganapathy, V.; Ganapathy, M. E. Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2. J. Pharm. Sci. 2000, 89, 781-789.
17. Shu, C.; Shen, H.; Hopfer, U.; Smith, D. E. Mechanism of intestinal absorption and renal reabsorption of an orally active ACE inhibitor: uptake and transport of fosinopril in cell cultures. Drug Metab. Dispos. 2001, 29, 1307-1315.
18. +/peptide cotransporter PEPT1 and PEPT2 in intestinal and renal epithelial cells. Eur. J. Biochem. 2004, 271, 2012-2017.
19. Shen, H.; Keep, R. F.; Hu, Y.; Smith, D. E. PEPT2 (Slc15a2)-mediated unidirectional transport of cefadroxil from CSF into choroid plexus. J. Pharmacol. Exp. Ther. 2005, 315, 1101-1108.
20. Boll, M.; Herget, M.; Wagener, M.; Weber, W. M.; Markovich, D.; Biber, J.; Clauss, W.; Murer, H.; Daniel, H. Expression cloning and functional characterization of the kidney cortex high-affinity proton-coupled peptide transporter. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 284-289.
21. +/peptide cotransporters in rat renal brush-border membranes. J. Pharmacol. Exp. Ther. 1998, 286, 1037-1042.
22. Rubio-Aliga, L.; Daniel, H. Mammalian peptide transporters as targets for drug delivery. Trends Pharmacol. Sci. 2002, 23, 434-440.
23. Groneberg, D. A.; Fischer, A.; Chung, F.; Daniel, H. Molecular mechanisms of pulmonary peptidomimetic drug and peptide transport. Am. J. Respir. Cell Mol. Biol. 2004, 30, 252-260.
24. +/peptide cotransporter in rat digestive tract. Biochim. Biophys. Acta 1996, 220, 848-852.
25. Zhou, X.; Thamotharan, M.; Gangopadhyay, A.; Serdikoff, C.; Adibi, S. A. Characterization of an oligopeptide transporter in renal lysosomes. Biochim. Biophys. Acta 2000, 1466, 372-378.
26. Bockman, D. E.; Ganapathy, V.; Oblak, T. G.; Leibach, F. H. Localization of peptide transporter in nuclei and lysosomes of the pancreas. Int. J. Pancreatol. 1997, 22, 221-225.
27. +-peptide cotransport in the human bile duct epithelium cell line SK-ChA-1. Am. J. Physiol.: Gastrointest. Liver Physiol. 2002, 283, G222-G229.
28. Thamotharan, M.; Lombardo, Y. B.; Bawani, S. Z.; Adibi, S. A. An active mechanism for completion of the final stage of protein degradation in the liver, lysosomal transport of dipeptides. J. Biol. Chem. 1997, 272, 11786-11790.
29. +/peptide symporter PEPT1: structure-affinity relationships. Eur. J. Pharm. Sci. 2004, 21, 53-60). A few of them might be inhibitors.
30. Terada, T.; Sawada, K.; Irie, M.; Saito, H.; Hashimoto, Y.; Inui, K. Structural requirements for determining the substrate affinity of peptide transporters PEPT1 and PEPT2. Pflügers Arch. 2000, 440, 679-684.
31. +/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPTl. Eur. J. Pharm. Biopharm. 2005, 59, 17-24.
32. + symporter. J. Clin. Invest. 1993, 92, 2215-2223.
33. +/peptide cotransporter PEPT1: localization of PEPT1 and transport of beta-lactam antibiotics. J. Pharmacol. Exp. Ther. 1997, 281, 1415-1421.
34. Daniel, H.; Rubio-Aliaga, I. An update on renal peptide transporters. Am. J. Physiol.: Renal Physiol. 2003, 284, F885-F892.
35. Daniel, H.; Adibi, S. A. Functional separation of dipeptide transport and hydrolysis in kidney brush border membrane vesicles. FASEB J. 1994, 8, 753-759.
36. + symporter in the renal brush border membrane. J. Biol. Chem. 1992, 267, 9565-9573.
37. Terada, T.; Saito, H.; Mukai, M.; Inui, K. Recognition of beta-lactam antibiotics by rat peptide transporters, PEPT1 and PEPT2, in LLC-PK1 cells. Am. J. Physiol.: Renal Physiol. 1997, 275, F706-F711.
38. +/peptide cotransporter PEPT2 using novel amino acid and dipeptide derivatives. Mol. Pharm. 2002, 61, 214-221.
39. +/peptide transporter PEPT2. J. Biol. Chem. 2002, 277, 7287-7292.
40. Vabeno, J.; Lejon, T.; Nielsen, C. U.; Steffansen, B.; Chen, W.; Ouyang, H.; Borchardt, R. T.; Luthman, K. Phe-Gly dipeptidomimetics designed for the di-/tripeptide transporters PEPT1 and PEPT2: synthesis and biological investigations. J. Med. Chem. 2004, 47, 1060-1069.
41. +/peptide symporter PEPT2: structure-affinity relationships. Amino Acids 2006, in press.
42. +/peptide cotransporter system, PEPT1. Eur. J. Biochem. 1998, 255, 698-702.
43. Knütter, I.; Hartrodt, B.; Theis, S.; Foltz, M.; Rastetter, M.; Daniel, H.; Neubert, K.; Brandsch, M. Analysis of the transport properties of side chain modified dipeptides at the mammalian peptide transporter PEPT1l. Eur. J. Pharm. Sci. 2004, 21, 61-47.
44. Swaan, P. W.; Koops, B. C.; Moret, E. E.; Tukker, J. J. Mapping the binding site of the small intestinal peptide carrier (PepT1) using comparative molecular field analysis. Recept. Channels 1998, 6, 189-200.
45. +/peptide cotransporter PEPT1. J. Med. Chem. 2003, 46, 5725-5734.
46. +/peptide cotransporter PEPT1. J. Med. Chem. 2005, 48, 4410-4419.
47. Ekins, S.; Johnston, J. S.; Bahadduri, P. M.; D'Souza, V. M.; Ray, A.; Chang, C.; Swaan, P. W. In vitro and pharmacophore-based discovery of novel hPEPT1 inhibitors. Pharm. Res. 2005, 22, 512-517.
48. Wanchana, S.; Yamashita, F.; Hara, H.; Fujiwara, S.; Akamatsu, M.; Hashida, M. Two- and three-dimensional QSAR of carrier-mediated transport of β-lactam antibiotics in caco-2 cells. J. Pharm. Sci. 2004, 93, 3057-3065.
49. +/peptide transporters. Nova Acta Leopold. 2003, 87, 75-85.
50. +/peptide cotransport systems in intestine (PEPT1) and in kidney (PEPT2). Biochim. Biophys. Acta 1997, 1324, 251-262.
51. +/peptide cotransporter. FASEB J. 1995, 9, 1489-1496.
52. Böhm, M.; Stürzebecher, J.; Klebe, G. Three-dimensional quantitative structure-activity relationship analyses using comparative molecular field analysis and comparative molecular similarity indices analysis to elucidate selectivity differences of inhibitors binding to trypsin, thrombin and factor Xa. J. Med. Chem. 1999, 42, 458-477.
53. Type I β-lactam antibiotics possess an N-terminal aminothiazole ring, and all other β-lactam antibiotics are combined as type II.
54. +/peptide symporter. Eur. J. Biochem. 1999, 266, 502-508.
55. SYBYL 7.0; Tripos Asscociates, Inc., St. Louis, MO, 2004.
56. Cohen, N. C. β-Lactam antibiotics: geometrical requirements for antibacterial activities. J. Med. Chem. 1983, 26, 259-264.
57. Allen, F. H.; Davies, J. E.; Galloy, J. J.; Jonson, O.; Kennard, O.; Macrae, C. F.; Mitchell, E. M.; Mitchell, G. F.; Smith, J. M.; Watson, D. G. The development of versions 3 and 4 of the Cambridge Structural Database System. J. Chem. Inf. Comput Sci. 1991, 31, 187-204.
58. Muranushi, N.; Yoshikawa, T.; Yoshida, M.; Oguma, T.; Hirano, K.; Yamada, H. Transport characteristics of Ceftibuten, a new oral cephem, in rat intestinal brush-border membrane vesicles: relationship to oligopeptide and amino β-lactam transport. Pharm. Res. 1989, 6, 308-312.
59. +/peptide symporter (PEPT1), the uptake into caco-2 cell monolayers and the transepithelial flux. Pharm. Res. 1999, 16, 55-61.